On 26 May 2022 AIFA, in collaboration with the Virtual Physiological Human Institute, will be hosting a workshop on “The role of In Silico Medicine in diabetes”.

Building on technological progress in the biomedical and computational field, In Silico Medicine aims to optimise and accelerate the (pre-)clinical development of novel medicinal products, integrating efficacy and safety evidence generated by experimental studies with computational modelling and simulation.

The dialogue between regulatory authorities, academia and industry is pivotal to promote the adoption of innovative approaches throughout the various stages of new medicinal product development.

The workshop will be held in English and will be live streamed on AIFA’s YouTube channel starting from 11am.

The workshop agenda is available in "Related documents".